WUXI BIO (02269) announced that on November 10, 2025, the company issued a total of 4.055 million ordinary shares pursuant to the exercise of options under its Pre-IPO Share Option Scheme adopted on January 5, 2016, and amended on August 10, 2016.
WUXI BIO (02269) announced that on November 10, 2025, the company issued a total of 4.055 million ordinary shares pursuant to the exercise of options under its Pre-IPO Share Option Scheme adopted on January 5, 2016, and amended on August 10, 2016.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。